Analytics
CareVention HealthCare, a division of Tabula Rasa HealthCare, launched a remote patient monitoring service that uses biosensors and artificial intelligence to monitor patients’ vital signs and alert providers if necessary.
Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.
AI algorithms will inform treatment decisions by recognising patterns of data from past treatments.
This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010.
Doctors are dealing with information overload, but tech could help.
The companies will combine their complementary pathology tools to leverage services for tech-enabled diagnostics, drug discovery and patient care.
The new capital boosts Olive’s valuation to $4 billion.
The industry has accepted that digital is here to stay, with 87% of executives saying their organization’s business and technology strategies are becoming inseparable.
HIMSS21
At HIMSS' State of Healthcare event on June 15, Oscar CEO Mario Schlosser will discuss how the insurance space has adjusted to the COVID-19 demands.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.